A PYMNTS Company

Australia: ACCC approves giant pharmaceutical merger

By  |  September 20, 2018

The ACCC has announced that it will not oppose the merger of generics companies Arrow and Apotex. Once combined, the two companies would supply around half the market for generic prescription pharmaceuticals to pharmacies in Australia.

The announcement that Strides Pharma Science Ltd and Apotex Inc planned to merge Arrow Pharmaceuticals and Apotex Australia was made on May 18, 2018.

The ACCC says that after market inquiries and analysis of documents and data, the ACCC considers that the merger will not substantially reduce competition in any market.

Full Content: AJP

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.